In part 1 of this series I discuss the magnitude of NAFLD/NASH and introduce a company that is a leader in NASH fibrosis. The idea is this; "anyone can potentially double, triple, or even quadruple their net worth getting in the right companies now". The key words being "right companies". With so many vying to be first to market developing exciting products its easy to get lost in the hype. To that end, I am going to use this series to present an objective analysis of NAFLD/NASH companies poised to succeed for our members. Don't sleep on . . .